US Diabetes Market Report: 2016 - 2020

May 2016 | 44 pages | ID: U3B1E513E72EN
IMARC Group

Abstracts

IMARC’s new report “US Diabetes Market Report: 2016 - 2020” provides an analytical and statistical insight into the US diabetes market. The report provides both current and future trends in the prevalence, demographical breakup, diagnosis and treatment of diabetes in the United States. The research study serves as an exceptional tool to understand the epidemiology, market trends, therapeutic structure, competitive structure and the outlook of the US diabetes market. This report can serve as an excellent guide for investors, researchers, consultants, marketing strategists and all those who are planning to foray into the US diabetes market in any form.

What we have achieved in this report:

Comprehensive situation analysis of the US diabetes epidemiology and its dynamics:

Focus of the Analysis:

• Historical, current and future prevalence of diabetes in US
• Historical, current and future prevalence of type-1 and type-2 diabetes in US
• Historical, current and future prevalence of diabetes in the urban and rural regions in US
• Historical, current and future prevalence of diabetes among males and females in US
• Historical, current and future prevalence of diabetes among various age groups in US
• Historical, current and future diagnosis rates for diabetes in US
• Historical, current and future drug treatment rates for diabetes in US

Comprehensive situation analysis of the US Oral Antidiabetics market and its dynamics:

Focus of the Analysis:

• Performance of the Oral Antidiabetics market in US
• Performance of key classes
• Performance of key players
• Market outlook

Comprehensive situation analysis of the US Insulin market and its dynamics:

Focus of the Analysis:

• Performance of the Insulin market in US
• Performance of key classes
• Performance of key players
• Market outlook

Contents

1 RESEARCH METHODOLOGY

2 EXECUTIVE SUMMARY

3 DIABETES DISEASE OVERVIEW

3.1 What is Diabetes?
3.2 Diabetes Diagnosis and Treatment
  3.2.1 Diagnosis
  3.2.2 Treatment
3.3 Diabetes Complications

4 KEY FACTORS DRIVING THE DIABETES MARKET IN US

5 US DIABETES EPIDEMIOLOGY

5.1 Diabetes Population and Prevalence Rates
5.2 Population and Prevalence Rates by Diabetes Type (Type-1 and Type-2)
5.3 Population and Prevalence Rates by Region
5.4 Population and Prevalence Rates by Gender
5.5 Population and Prevalence Rates by Age Group

6 US DIABETES MARKET

6.1 Historical Market Trends
6.2 Market Outlook
6.3 Market Breakup by Segment
6.4 US Oral Antidiabetics Market
  6.4.1 Historical Market Trends
  6.4.2 Market Breakup by Class
  6.4.3 Market Shares of Key Players
  6.4.4 Market Outlook
6.5 US Insulin Market
  6.5.1 Historical Market Trends
  6.5.2 Market Breakup by Class
  6.5.3 Market Shares of Key Players
  6.5.4 Market Outlook

List Of Figures

LIST OF FIGURES

Figure 3 1: The impact of Diabetes in the Human Body
Figure 3 2: Diabetes Complications
Figure 4 1: Global: Breakup of Diabetes Patients by Region, (in %) 2015 & 2035
Figure 4 2: US: Overweight & Obese Population* (in Million), 2010, 2015 & 2020
Figure 4 3: Body Mass Index and Relative risk of Type-2 Diabetes
Figure 4 4: US: Breakup of Total Population by Age Groups (0-14, 15-64 & 65+), (in %)
Figure 4 5: US: Diabetes Prevalence By Age Groups, (in %)
Figure 5 1: US: Total Number of Diabetes Patients* (in 000), 2008-2015
Figure 5 2: US: Total Number of Diabetes Patients* Forecast (in 000), 2016-2020
Figure 5 3: US (Type1 & Type2): Total Number of Diabetes Patients* (in 000), 2008- 2015
Figure 5 4: US (Type1 & Type2): Total Number of Diabetes Patients* (in 000),2016-2020
Figure 5 5: US (Urban & Rural): Total Number of Diabetes Patients* (in 000), 2008 -2015
Figure 5 6: US (Urban & Rural): Total Number of Diabetes Patients* (in 000), 2016 - 2020
Figure 5 7: US (Male & Female): Total Number of Diabetes Patients* (in 000), 2008 - 2015
Figure 5 8: US (Male & Female): Total Number of Diabetes Patients* (in 000), 2016 - 2020
Figure 5 9: US: Total Number of Diabetes Patients by Age Group (20-39), (40-59) & (60-79) (in 000), 2008 - 2015
Figure 5 10: US: Total Number of Diabetes Patients by Age Group (20-39), (40-59) & (60-79) (in 000), 2016 - 2020
Figure 6 1: US: Diabetes Drugs Market (in Million US$), 2008 - 2015
Figure 6 2: US: Diabetes Drug Market Forecast (in Million US$), 2016 - 2020
Figure 6 3: US: Diabetes Drugs Market: Breakup of Insulin and Oral Antidiabetics (in %), 2008- 2015
Figure 6 4: US: Diabetes Drugs Market Forecast: Breakup of Insulin and Oral Antidiabetics (in %), 2016 - 2020
Figure 6 5: US: Oral Antidiabetics Market: (in Million US$), 2008 - 2015
Figure 6 6: US: Oral Antidiabetics Market: Sales Share of Key Classes (in %), 2008 & 2015
Figure 6 7: US: Oral Anti-diabetics Market: Sales Share of Key Players (in %)
Figure 6 8: US: Oral Antidiabetics Market: (in Million US$), 2016 - 2020
Figure 6 9: US: Oral Antidiabetics Market: Sales Share of Key Classes (in %), 2016 & 2020
Figure 6 10: US: Insulin Market, (in Million US$), 2008 - 2015
Figure 6 11: US: Breakup of Insulin Market by Class (in %)
Figure 6 12: US: Insulin Market: Sales Share of Key Players (in %)
Figure 6 13: US: Insulin Market Forecast (in Million US$), 2016 - 2020

List Of Tables

LIST OF TABLES

Table 3 1: Diagnosis of Diabetes
Table 4 1: Global: Diabetes Population Breakup by Country (in 000’s), 2015 & 2035
Table 4 2: US: Overweight &Obesity Statistics, 2010, 2015 & 2020
Table 4 3: US: Breakup of Total Population by Age Groups (0-14, 15-64 & 65+), (in Million)
Table 5 1: US: Total Prevalence & Number of Diabetes Patients*, 2008, 2015 & 2020
Table 5 2: US (Type1 & Type2): Total Prevalence & Number of Diabetes Patients, 2008, 2015 & 2020
Table 5 3: US (Urban & Rural): Total Prevalence & Number of Diabetes Patients, 2008, 2015 & 2020
Table 5 4: US (Male & Female): Total Prevalence & Number of Diabetes Patients, 2008, 2015 & 2020
Table 5 5: Total Prevalence & Number of Diabetes Patients by Age Group (20-39), (40-59) & (60-79) (In Millions), 2008, 2015 & 2020